Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 95-100

  Montaldo, Paolo G ^a   Raffaghello, Lizzia ^a   Guarnaccia, Francesco ^a   Pistoia, Vito ^a   Garaventa, Alberto ^a   Ponzoni, Mirco ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 125; CARRIER PROTEIN; GAMMA INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW DEPRESSION; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; DRUG UPTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOTOPE LABELING; NEUROBLASTOMA CELL; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

3-IODOBENZYLGUANIDINE; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; HALF-LIFE; HUMANS; INTERFERON TYPE II; IODOBENZENES; NEUROBLASTOMA; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030038672     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<95::AID-IJC16>3.0.CO;2-B     Document Type: Article

References (32)

1. ABEMAYORE. and SIDELLN., Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ. Health Perspect., 80, 3-15 (1989).
2. AVANZIG.C., BRIZZI, M.F., GIANNOTTI, J., CIARLETTA, A., YANG, Y.C., PEGORARO, L. and CLARK, S.C., M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J. cell. Physiol., 145, 458-464 (1990).
3. BIEDLERJ.L., HELSON, L. and SPENGLER, B.A., Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res., 33, 2643-2652 (1973).
4. BIEDLERJ.L., ROFFER-TARLOV, S., SCHACHNER, M. and FREEDMAN, L.S., Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res., 38, 3751-3757 (1978).
5. CHOMCZYNSKIP. and SACCHIN., Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1982).
6. 131I]iodobenzylguanidine in patients. Cancer Res., 47, 6147-6149 (1987).
7. FUGMAND.A., WITTE, D.P., JONES, C.L.A., ARONOV, B. and LIEBERMAN, M.A., In vitro establishment and characterization of a human megakaryoblastic cell line.Blood, 75, 1252-1261 (1990).
8. HOEFNAGELC.A., Radionuclide therapy revisited. Europ. J. nucl. Med., 18, 408-431 (1991).
9. 131I-Metaiodobenzylguanidine in patients with refractory advanced neuroblastoma. Amer. J. clin. Oncol., 15, 226-232 (1992).
10. 131I-M]IBG. Adv. Neuroblastoma Res., 4, 309-317 (1994).
11. LANCIOTTIM., MONTALDO, P.G., FOLGHERA, S., LUCARELLI, E., CORNAGLIA-FERRARIS, P. and PONZONI, M., A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation. Cell. mol. Neurobiol., 12, 225-240 (1992).
12. LASHFORDL.S., HANCOCK, J.P. and KEMSHEAD, J.T., Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C). Int. J. Cancer, 47, 105-109 (1991).
13. LEVYD.E., LEW, D.J., DECKER, T., KESSLER, D.S. and DARNELL JR., J.E., Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J., 9, 1105-1111 (1990).
14. LEWD.J., DECKER, T. and DARNELL JR., J.E., Alpha Interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. cell. Biol., 9, 5404-5411 (1989).
15. LONGOL., CHRISTIANSEN, H., CHRISTIANSEN, N.M., PAULSEN, P., CORNAGLIA-FERRARIS, P. and LAMPERT, F., N-myc amplification at chromosome band Ip32 in neuroblastoma cells as investigated by in situ hybridization. J. Cancer Res. clin. Oncol., 114, 636-640 (1988).
16. LOWRYO.H., ROSEBROUGH, N.J., PARR, A.L. and RANDALL, R.J., Protein measurement with the Folin phenol reagent. J. biol. Chem., 193, 265-275 (1951).
17. 131I-labelled metaiodobenzylguanidine in neuroblastoma cell lines by means of reverse-transcription and polymerase chain reaction. Brit. J. Cancer, 70, 97-101 (1994).
18. MONTALDOP.G., CARBONE, R., CORRIAS, M.V., CORNAGLIA-FERRARIS, P. and PONZONI, M., Synergistic differentiation-promoting activity of interferon γ and tumor necrosis factor-α: role of receptor regulation on human neuroblasts. J. nat. Cancer Inst., 86, 1694-1701 (1994).
19. MONTALDOP.G., CARBONE, R., PONZONI, M. and CORNAGLIA-FERRARIS, P., γ-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells. Cancer Res., 52, 4960-4964 (1992).
20. MONTALDOP.G., LANCIOTTI, M., CASALARO, A., CORNAGLIA-FERRARIS, P. and PONZONI, M., Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Cancer Res., 51, 4342-4346 (1991).
21. PACHOLCZYKT., BLAKELY, R.D. and AMARA, S.G., Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (Lond.), 350, 350-353 (1991).
22. PATTERSONP.H., Control of cell fate in a vertebrate neurogenic lineage. Cell, 62, 1035-1038 (1990).
23. PONZONIM., CASALARO, A., LANCIOTTI, M., MONTALDO, P.G. and CORNAGLIA-FERRARIS, P., The combination of γ-Interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res., 52, 931-939 (1992).
24. RABELLINOE.M., NACHMAN, R.L., WILLIAMS, M., WINCHESTER, R.J. and Ross, G.D., Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J. exp. Med., 149, 1273-1287 (1979).
25. RUTGERSM., TYTGAT, G.A.M., VERWIJS-JANSSEN, M., BUITENHUIS, C., VOUTE, P.A. and SMETS, L.A., Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells. Int. J. Cancer, 54, 290-295 (1993).
26. SEEGERR.C., DANON, Y.L., RAYNER, S.A. and HOOVER, F., Definition of aThy-1 determinant of human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J. Immunol., 128, 983-989 (1982).
27. SMETSL.A., JANSSEN, M., RUTGERS, M., RITZEN, K. and BUITENHUIS, C., Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells. Int. J. Cancer, 48, 609-615 (1991).
28. SMETSL.A., LOESBERG, C., JANSSEN, M., METWALLY, E.A. and HUISKAMP, R., Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. Cancer Res., 49, 2941-2944 (1989).
29. TUMILOWICZJ.J., NICHOLS, W.W., CHOLON, J.J. and GREENE, A., Definition of a continuous human cell line derived from neuroblastoma. Cancer Res., 30, 2110-2118 (1970).
30. 131-MIBG) in neuroblastoma patients. Adv. Neuroblastoma Res., 2, 679-687 (1988).
31. 131I-MIBG in patients with neuroblastoma. Future prospects for zetotherapy. Adv. Neuroblastoma Res., 3, 439-445 (1991).
32. WUARINL., VERITY, M.A. and SIDELL, N., Effects of interferon-γ and its interaction with retinoic acid on human neuroblastoma differentiation. Int. J. Cancer, 48, 136-141 (1991).